Triplet combination of endocrine therapy with CDK 4/6 inhibitor, ribociclib, and MTOR inhibitor, everolimus in HR+, HER2-ABC: Results from the dose-expansion cohort Meeting Abstract
| Authors: | Bardia, A.; Cortés, J.; Modi, S.; Oliveira, M.; Campone, M.; Ma, B.; Dirix, L.; Weise, A.; Kittaneh, M.; Hewes, B.; Wang, Y.; Stegert, M.; Elmeliegy, M.; Liu, X.; Chavez-Macgregor, M. |
| Abstract Title: | Triplet combination of endocrine therapy with CDK 4/6 inhibitor, ribociclib, and MTOR inhibitor, everolimus in HR+, HER2-ABC: Results from the dose-expansion cohort |
| Meeting Title: | 4th International Consensus Conference for Advanced Breast Cancer (ABC4) |
| Journal Title: | Breast |
| Volume: | 36 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Nov 2-4 |
| Meeting Location: | Lisbon, Portugal |
| ISSN: | 0960-9776 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-11-01 |
| Start Page: | S46 |
| End Page: | S47 |
| Language: | English |
| ACCESSION: | WOS:000414258900071 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0960-9776(17)30691-4 |
| Notes: | Meeting Abstract: PO72 -- Source: Wos |
